During the past decade, Skellefteå Lasarett conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Skellefteå Lasarett" #1 sponsor was "Pfizer" with 3 trials, followed by "Uppsala University" with 3 trials sponsored, "Bayer" with 2 trials sponsored, "Diamyd Therapeutics AB" with 1 trials sponsored and "Ionis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Skellefteå Lasarett" #1 collaborator was "Air Force Military Medical University, China" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Helsingborgs Hospital" with 1 trials as a collaborator, "Kalmar County Hospital" with 1 trials as a collaborator and "Karolinska University" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Skellefteå Lasarett" are "Cardiovascular Disease" (2 trials), "Atrial Fibrillation" (1 trials), "Atrial Fibrillation (AF)" (1 trials), "Breast Neoplasms" (1 trials) and "Colonic Neoplasms" (1 trials). Many other conditions were trialed in "Skellefteå Lasarett" in a lesser frequency.

Most popular intervention types in "Skellefteå Lasarett" are "Drug" (9 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Apixaban" (2 trials), "Apixaban matching placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Aquacel Extra Hydrofiber® Dressing with Strengthening Fibre" (1 trials). Other intervention names were less common.

The vast majority of trials in "Skellefteå Lasarett" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Skellefteå Lasarett". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Skellefteå Lasarett, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Skellefteå Lasarett, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".